Health

Pharma Updates and Dealings

Updated 2026-05-29 13:50 UTC 1 source Neutral

Replimune’s drug faces a third attempt at FDA approval, while Pfizer has secured a new deal in China. These developments highlight ongoing changes in the pharmaceutical industry.

Coverage timeline — 1 article

STAT News

STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

Pharma updates from the Pharmalot campus via the Pharmalittle newsletter

2026-05-29 13:34 UTC